TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Click for best price
| Market size in 2024 | US$ 7.84 billion |
Forecast Market size by 2030 | US$ 12.76 billion |
|---|---|---|---|
| Growth Rate | CAGR of 8.4% | Number of Pages | 110 Pages |
The global GMP Biologics market size was valued at US$ 7.84 billion in 2024 and is projected to reach US$ 12.76 billion by 2030, at a CAGR of 8.4% during the forecast period 2024-2030.
The United States GMP Biologics market size was valued at US$ 2.08 billion in 2024 and is projected to reach US$ 3.24 billion by 2030, at a CAGR of 7.7% during the forecast period 2024-2030.
Biopharmaceutical products manufactured under Good Manufacturing Practice (GMP) standards, ensuring quality, safety, and efficacy in the production of biological medicines.
The global GMP Biologics market is experiencing robust growth, driven by increasing demand for biologic drugs, advancements in biotechnology, and stringent regulatory requirements in pharmaceutical manufacturing. Key players include Lonza, Samsung Biologics, and Boehringer Ingelheim. In 2024, monoclonal antibodies accounted for 48% of the market, with cell and gene therapies showing the fastest growth at 12.5% CAGR. The industry is seeing significant investment in single-use technologies and continuous manufacturing processes, improving flexibility and reducing production costs. There's growing demand for contract manufacturing services, with CMOs capturing 35% of the GMP biologics production market. Manufacturers are developing advanced analytical techniques for better product characterization and quality control, commanding a 20% premium for enhanced purity assurance. The market is benefiting from the increasing prevalence of chronic diseases and the shift towards personalized medicine. Challenges include high production costs and complex regulatory pathways for biosimilars. The US market leads in innovation and clinical trials, with a strong focus on novel biologic therapies for oncology and autoimmune diseases.
Report Overview
This report provides a deep insight into the global GMP Biologics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global GMP Biologics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the GMP Biologics market in any manner.
Global GMP Biologics Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Creative Diagnostics
Fisher Bioservices(Thermo Fisher Scientific)
Polpharma Biologics
Intertek
HemaCare
AGC
Market Segmentation (by Type)
Monoclonal Antibodies
Polyclonal Antibody
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the GMP Biologics Market
Overview of the regional outlook of the GMP Biologics Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the GMP Biologics Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
| Report Attributes | Report Details |
|---|---|
| Report Title | Global GMP Biologics Market Research Report 2024(Status and Outlook) |
| Market size in 2024 | US$ 7.84 billion |
| Forecast Market size by 2030 | US$ 12.76 billion |
| Growth Rate | CAGR of 8.4% |
| Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year | 2023 |
| Forecast Year | 2031 |
| Number of Pages | 110 Pages |
| Customization Available | Yes, the report can be customized as per your need. |
Frequently Asked Questions ?
